Richard Mejia Jr insider trades: Ra Medical Systems (RMED) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 19, 2020 | RMED | ↑ Buy | 1,000 | $5.82 | $6K | Direct | Nov 23, 2020 (4d) |
| Jun 12, 2020 | RMED | ↑ Buy | 50,000 | $0.60 | $30K | Direct | Jun 15, 2020 (3d) |
| Aug 13, 2012 | HILL | ↑ Buy | 12,500 | $1.14 | $14K | Direct | Aug 15, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard Mejia Jr's insider trades
Richard Mejia Jr is a director at Ra Medical Systems (RMED). Since Aug 13, 2012, Richard has reported 3 open-market purchases worth $50K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.